0001209191-23-024255.txt : 20230413 0001209191-23-024255.hdr.sgml : 20230413 20230413202140 ACCESSION NUMBER: 0001209191-23-024255 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230413 DATE AS OF CHANGE: 20230413 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morris Shannon CENTRAL INDEX KEY: 0001973527 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40602 FILM NUMBER: 23819489 MAIL ADDRESS: STREET 1: C/O ERASCA, INC. STREET 2: 3115 MERRYFIELD ROW, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-04-10 0 0001761918 Erasca, Inc. ERAS 0001973527 Morris Shannon C/O ERASCA, INC. 3115 MERRYFIELD ROW, SUITE 300 SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 7.91 2032-05-01 Common Stock 300000 D Stock Option (Right to Buy) 4.00 2033-01-31 Common Stock 160800 D 25% of the shares subject to the options vest on May 2, 2023, the one-year anniversary of the vesting commencement date, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. 1/48th of the shares subject to the option vest monthly following February 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. /s/ Shannon Morris 2023-04-13